GLPBio

Apoptosis

Read More about this category

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

 

References:

1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.

2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.

3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.

4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.

5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

Research Areas

Products Related to Apoptosis(3359)

  • GC70868 structure
    GC70868Nrf2 activator-3
    CAS: 2766570-23-2
    Purity: >98.00%

    Nrf2 activator-3 est un puissant activateur Nrf2.

  • GC70875 structure
    GC70875RIPK1-IN-9
    CAS: 2682889-57-0

    RIPK1-IN-9 (example 45) est un composé dihydronaphtyridone, inhibiteur puissant et sélectif de ripk1.

  • GC70941 structure
    GC70941ISIS 104838 sodium
    Purity: >93.00%

    ISIS 104838 sodium is an antisense oligonucleotide agent that reduces the production of tumor necrosis factor (TNF-alpha), a substance that contributes to joint pain and swelling in rheumatoid arthritis.

  • GC71008 structure
    GC71008BBR-BODIPY
    CAS: 2456476-47-2
    Purity: >98.00%

    BBR-BODIPY est une sonde fluorescente qui permet de cribler son interaction avec les cellules ciblées.

  • GC71031 structure
    GC71031Nrf2 activator-6
    CAS: 2728780-74-1

    Nrf2 activator-6 Le composé Tétrahydroisoquinoléine est un activateur nrf2.

  • GC71050 structure
    GC71050Oditrasertib
    CAS: 2252271-93-3
    Purity: >98.00%

    Oditrasertib est un inhibiteur de la protéine kinase 1 (ripk1) à interaction de récepteur dont la CI50 est inférieure à 100 nm.

  • GC71072 structure
    GC71072NXPZ-2
    CAS: 2254492-08-3
    Purity: >98.00%

    NXPZ-2 est un inhibiteur de l'interaction protéine - protéine (IPP) keap1 - nrf2 actif par voie orale avec un ki de 95 nm et des CE50 de 120 et 170 nm.

  • GC71119 structure
    GC71119UBX1325
    CAS: 2271269-01-1
    Purity: >98.00%

    UBX1325 est un inhibiteur de Bcl - XL qui favorise l'apoptose dans les cellules vieillissantes.

  • GC71128 structure
    GC71128Diclofenac-d4 sodium
    CAS: 154523-54-3
    Purity: >99.00%

    Diclofenac-d4 sodium est du Diclofénac sodique marqué au deutérium.

  • GC71180 structure
    GC71180SZM679
    CAS: 3027645-52-6
    Purity: >99.00%

    SZM679 est un inhibiteur puissant, actif par voie orale et sélectif de ripk1 avec des valeurs de KD de 8,6 nm pour ripk1 et > 5 000 nm pour ripk3.

  • GC71214 structure
    GC71214CZL55
    CAS: 667408-87-9
    Purity: >98.00%

    CZL55 est un inhibiteur de la caspase - 1 avec une IC50 de 24 nm.

  • GC71232 structure
    GC71232I-152
    CAS: 311343-11-0
    Purity: >98.00%

    I-152 est un conjugué contenant de la n-acétyl-cystéine (NAC) et de la cystéamine (MEA).

  • GC71258 structure
    GC71258ASK1-IN-4
    CAS: 1427538-26-8

    ASK1-IN-4 (composé 17) est un inhibiteur de l'ASK1 (IC50 = 0,2 µm).

  • GC71298 structure
    GC71298DRI-C21041 (DIEA)

    DRI-C21041 (DIEA) est un inhibiteur d’interaction CD40/CD40L, avec une ci50 de 0,31 μM.

  • GC71355 structure
    GC71355Zharp2-1
    CAS: 2772600-18-5
    Purity: >99.00%

    Zharp2-1 est un inhibiteur de RIPK2 oral efficace, fortement associé à la maladie inflammatoire de l’intestin (mii).

  • GC71380 structure
    GC71380UCB-6876
    CAS: 637324-45-9
    Purity: >99.00%

    UCB-6876 est un inhibiteur de TNFα et se lie à la forme de cristal asymétrique du trimer de TNF (KD = 22 μM).

  • GC71507 structure
    GC715075'-Methylthioadenosine-13C6
    CAS: 2421187-73-5

    5'-Methylthioadenosine-13C6 est la 5 '- méthylthioadnosine marquée au 13C.

  • GC71541 structure
    GC71541BMS-561392 formate
    CAS: 2922280-85-9

    BMS-561392 formate est la forme Formiate de BMS - 561392.

  • GC71544 structure
    GC71544Antroquinonol
    CAS: 1010081-09-0
    Purity: >98.00%

    Antroquinonol (+) - Antroquinonol), un dérivé de l'ubiquinone dérivé du champignon Antrodia Camphorata, qui a des effets hépatoprotecteurs, anti - inflammatoires et anticancéreux.

  • GC71607 structure
    GC71607Melatonin-d7
    CAS: 615251-68-8
    Purity: >98.00%

    Melatonin-d7 est la mélatonine marquée au deutérium.

  • GC71617 structure
    GC71617L-Ascorbic acid-13C-2
    CAS: 1313730-17-4
    Purity: >95.00%

    L-Ascorbic acid-13C-2 est de l'acide L - Ascorbique marqué au 13C.

  • GC71622 structure
    GC71622Prednisone-d8

    Prednisone-d8 est la Prednisone marquée au deutérium.

  • GC71624 structure
    GC71624Ketoprofen-d4
    CAS: 1219805-29-4
    Purity: >98.00%

    Ketoprofen-d4 est le kétoprofène marqué au deutérium.

  • GC71632 structure
    GC71632Meloxicam-d3-1
    CAS: 1227358-55-5
    Purity: >98.00%

    Meloxicam-d3-1 est le méloxicam marqué au deutérium.